Key Market Indicators
Chilean blood and blood forming organs medicine sales are expected to reach $234 million by 2026, growing at an average annual rate of 3%, according to a new report. Since 2005, the Chilean market has increased by 5.3% year-on-year. In 2021, Chile ranked 21st, with Hungary overtaking Chile's $190.7 million. Germany, Italy, and South Korea were ranked second, third, and fourth, respectively. Chilean anemia prevalence is expected to reach 6,730 hospital discharges by 2026, growing at an average annual rate of 0.7%. Since 2006, Chilean demand has decreased by 2.2%. In 2021, Chile ranked 20th, with Ireland overtaking Chile's 6,020 hospital discharges. Germany, the United Kingdom, and Poland were ranked second, third, and fourth, respectively.
